Dermatology
Proposal for the Addition of Adalimumab to the World Health Organization Model List of Essential Medicines for the Treatment of Adults and Children with Severe Psoriasis
Using population-based laboratory and health claims data from Ontario, Canada (2007–2022), investigators identified cases suggesting that MS onset may precede documented primary Epstein-Barr virus (EBV) infection.
Dermatology
Proposal for the Addition of Ustekinumab to the World Health Organization Model List of Essential Medicines for the Treatment of Adults and Children with Severe Psoriasis
In a large retrospective real-world analysis, process mining and deep learning techniques were applied to characterise patient trajectories associated with delayed MS diagnosis.